DE Research Update — August 28, 2026 (Updated)
Updated Thesis
Deere is a premium global agricultural, construction and forestry equipment manufacturer whose high-quality integrated model combines a powerful John Deere brand, dealer and service distribution, parts and lifecycle support, captive financing, and a growing precision-agriculture, automation and data ecosystem. Business fundamentals remain resilient but distinctly cyclical: in fiscal 3Q26, consolidated revenue grew 5% year over year to $12.608 billion and net income grew 7% to $1.379 billion, driven by Small Agriculture & Turf and Construction & Forestry, while Production & Precision Agriculture revenue fell 6%. TTM gross, operating and net margins of 35.7%, 19.0% and 10.2%, respectively, and 18.1% ROE support a high-quality franchise assessment, but the stock appears to price in a substantial recovery.
The investment grade as of this refresh is C — average business quality. High-tier business, very expensive-tier valuation, with 11.8% downside to $598.22 fair value.
Key Metrics at a Glance
- Revenue growth: +7.0% year over year
- Net margin: 10.2%
- Fair value upside: -11.8% to our estimate of $598
Current price: $677.94
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Deere & Company remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full DE research →](/stocks/DE)